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INTRODUCTION:  Upper  extremity  deep  vein  thrombosis  (UEDVT)  represents  approximately  10%  of all
thromboembolic  events.  It is  a rare  condition  after  a gynecologic  surgery  and  highly  related  with  pul-
monary  embolism.
PRESENTATION  OF  CASE:  Herein,  we  present  a  very  rare  case  of  a unilateral  left upper  extremity  deep  vein
thrombosis  in a morbidly  obese  patient  with  synchronous  primary  cancers  of endometrium  and  ovary.
DISCUSSION:  Our  aim  was to underline  the  relationship  between  the  presence  of gynecologic  malignancy,eywords:
pper extremity
eep vein thrombosis
ynecologic surgery
varian cancer
oncologic  surgery  and  UEDVT.
CONCLUSION:  Upper  extremity  deep  vein  thrombosis  should  be kept  in  mind  in the  presence  of any
symptom  on  upper  extremity  during  postoperative  period  even  in patients  without  central  venous
catheter.
 Publi
he CCndometrium cancer
besity
© 2016  The  Author(s).
access  article  under  t
. Introduction
Upper extremity deep vein thrombosis (UEDVT) describes the
ormation of ﬁbrin clot within the axillary, subclavian and brachial
eins of the arm [1]. Annual incidence of UEDVT has been estimated
s 0.4–1 per 10 000 patients. UEDVT approximately represents
0% of all thromboembolisms [2]. The incidence of UEDVT seems
o be rising which may  be related with growing prevalence of
alignancies, widespread use of central venous catheters and an
ging population [3]. UEDVT may  be primary; Paget Schroetter
yndrome and thoracic outlet syndrome are the most common
easons [4]. However, secondary causes are more frequently seen
uch as placement of central venous catheter, malignancy, trauma,
regnancy, oral contraceptive use, baseline coagulopathy [4–6].
ypically UEDVT presents as an edema, erythema and pain of
he affected extremity. Less commonly, paresthesias, weakness,
nd visible venous collaterals may  be the ﬁrst signs. It is easily
iagnosed by duplex ultrasonography [7]. Herein, a UEDVT in an
xtremely obese patient underwent gynecologic oncologic surgery
as presented. To our knowledge, this is the ﬁrst case report of
EDVT in a gynecologic oncology patient.∗ Corresponding author at: Cerrahpasa School of Medicine,Department of Obstet-
ics and Gynecology, Fatih, Istanbul, Turkey.
E-mail address: ilkerkahramanoglu@hotmail.com (I. Kahramanoglu).
ttp://dx.doi.org/10.1016/j.ijscr.2016.10.066
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/).shed  by Elsevier  Ltd on behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
A 39-year-old, gravida 0, para 0 woman  with abdominal disten-
sion was seen in our hospital. Her body mass index was 44 kg/m2.
She had been diagnosed with Hodgkin lymphoma in her child-
hood and received ABVD chemotherapy regimen (Doxorubicin,
Bleomycin, Vinblastine, Dacarbazine) and followed-up for 20 years
without recurrence. Her menstruation cycles were regular and
she had used no medications. After physical examination, labo-
ratory and imaging studies, patient underwent laparotomy with
presumed diagnosis of simultaneous ovarian and endometrial
cancer. A total hysterecotmy with bilateral salpingooophorec-
tomy, omentectomy and pelvic and paraaortic lymphadenectomy
were performed. Compression anti-embolic stock was worn before
surgery and prophylactic, low-molecular weight heparin (80 mg
enoxaparin, once a day) was  started 6 h after surgery. In the third
day of postoperative follow-up, she complained with left arm
swelling and pain. On exam, no color change but a signiﬁcant differ-
ence in circumference of the left arm when compared to the right
arm was  observed (Fig. 1). A compression Duplex ultrasonography
of the left arm demonstrated a large, nearly occlusive thrombus in
the left axillary vein extending to the left brachial vein (Fig. 2). D-
dimer level was within normal limits and there was  no abnormality
in thrombophilia screening including factor V Leiden mutation,
prothrombin mutation, antithrombin III, MTHFR mutation, protein
C and S functional and lupus anticoagulants. Chest radiography
was performed for right central venous catheter and no abnormal
ﬁnding was  observed. She was treated with therapeutic dose low-
molecular weight heparin (100 mg  enoxaparin, twice a day) for a
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. There was  a difference in circumference of the left arm (50.5 cm) (A) and forearm (36 cm)  (B) when compared to the right arm (38 cm)  (C) and forearm (27 cm) (D).
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vFig. 2. Ultrasound images of brachial vein thrombosis of the left arm. a. C
onth and continuation of the treatment for at least additional ﬁve
onths was planned. Follow-up 4 month after surgery showed a
esolution of arm sypmtoms and swelling. Patient received 6 cycles
f carboplatin and paclitaxel regimen as an adjuvant treatment.
Written informed consent was obtained from the patient. The
anuscript was prepared in accordance with the Surgical Case
eport (SCARE) guideline [8].. Discussion
According to the Agency for Healthcare Research and Quality,
enous thromboembolism (VTE) is the number one preventablel view. b. Sagittal view of thrombosed brachial extendig to axillary vein.
complication [9]. Without VTE prophylaxis, 38% of gynecological
oncology patients are expected to develop a thrombotic event. Even
with prophylaxis, 15% of these patients still develop perioperative
thromboembolic complication [10–12]. Patients with cancer have
almost a four-fold increase incidence of VTE following gynecologic
surgery [12,13].
Every gynecologic oncology patients require dual trompopro-
phylaxis [9]. However, preoperative use and dose of heparin is a
controversial issue. It has been shown that preoperative anticoag-
ulation (Low molecular weight heparin (LMWH), 40 mg, 2 h before
surgery) is signiﬁcantly associated with lower risk of VTE without
any harm such as higher blood loss [14]. Dual thromboprophy-
 –  O
1 of Surg
l
w
s
a
T
f
p
c
o
s
w
u
e
f
C
i
A
R
[
[
[
[
[
O
T
p
cCASE  REPORT
22 H. Turan et al. / International Journal 
axis with sequential compression devices and daily low molecular
eight heparin were given to patient. While sequential compres-
ion device started just before the operation, LMWH  started 6 h
fter the surgery.
UEDVT is infrequent, but has similar signiﬁcant clinical concern.
he morbidity and mortality associated with UEDVT, have been
ound to parallel that of lower extremity DVT [5]. However, genetic
redisposition may  be a major underlying cause particularly in
ases with thrombosis in atypical location, thrombophilia testing
f our patient showed normal results. Morbid obesity, oncologic
urgery, malignancy itself and presence of central venous catheter
ere the risk factors in this case.
In conclusion, DVT can be seen in atypical locations such as
pper extremity and requires the same attention as DVT in lower
xtremity. High index of suspicion is essential for early diagnosis
or UEDVT.
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